{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:11:48Z","timestamp":1789593108645,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.annder.2012.11.006","type":"journal-article","created":{"date-parts":[[2012,12,25]],"date-time":"2012-12-25T00:45:17Z","timestamp":1356396317000},"page":"120-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ulc\u00e9rations buccales aphto\u00efdes persistantes associ\u00e9es au tocilizumab\u00a0: deux cas"],"prefix":"10.1016","volume":"140","author":[{"given":"M.","family":"Samimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lauferon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"H\u00fcttenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vaillant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Goupille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Machet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2012.11.006_bib0005","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.23940","volume":"58","author":"Genovese","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2012.11.006_bib0010","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2008.092866","article-title":"Long-term safety and efficacy of tocilizumab, an anti-IL-6\u00a0receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study","volume":"68","author":"Nishimoto","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2012.11.006_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/s10165-008-0125-1","volume":"19","author":"Nishimoto","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.annder.2012.11.006_bib0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jbspin.2010.08.004","article-title":"Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists","volume":"77","author":"Brulhart","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.annder.2012.11.006_bib0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-011-1917-9","article-title":"Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review","volume":"31","author":"Sakai","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.annder.2012.11.006_bib0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/RHU.0b013e31823ecd73","article-title":"Successful use of interleukin 6\u00a0antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis","volume":"18","author":"Makol","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.annder.2012.11.006_bib0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/rheumatology\/ker296","article-title":"Tocilizumab: a novel therapy for patients with large-vessel vasculitis","volume":"51","author":"Salvarani","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.annder.2012.11.006_bib0040","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaci.2011.10.031","article-title":"Complete remission in 3\u00a0of 3\u00a0anti-IL-6-treated patients with Schnitzler syndrome","volume":"129","author":"Krause","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annder.2012.11.006_bib0045","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/rheumatology\/keq275","article-title":"The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6\u00a0receptor antibody tocilizumab","volume":"49","author":"Shima","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.annder.2012.11.006_bib0050","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/rheumatology\/keq343","article-title":"Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials","volume":"50","author":"Campbell","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.annder.2012.11.006_bib0055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/s10165-010-0366-7","article-title":"Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)","volume":"21","author":"Yamanaka","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.annder.2012.11.006_bib0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1468-3083.2009.03437.x","article-title":"Drug eruption induced by IL-6\u00a0receptor inhibitor tocilizumab","volume":"24","author":"Yoshiki","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2012.11.006_bib0065","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1365-2133.2010.10005.x","article-title":"Onset of psoriasis following treatment with tocilizumab","volume":"163","author":"Laurent","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2012.11.006_bib0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1684\/ejd.2009.0642","article-title":"Tocilizumab-induced erythroderma","volume":"19","author":"Nakamura","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.annder.2012.11.006_bib0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/s10165-008-0132-2","article-title":"A case of peripheral neuropathy and skin ulcer in a patient with rheumatoid arthritis after a single infusion of tocilizumab","volume":"19","author":"Sugiura","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.annder.2012.11.006_bib0080","first-page":"1426","article-title":"Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6\u00a0receptor antibody MRA in rheumatoid arthritis. Phase I\/II clinical study","volume":"30","author":"Nishimoto","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2012.11.006_bib0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-0030-1255931","article-title":"Multiple ulcers in the small and large intestines occurred during tocilizumab therapy for rheumatoid arthritis","volume":"43","author":"Iwasa","year":"2011","journal-title":"Endoscopy"},{"key":"10.1016\/j.annder.2012.11.006_bib0090","doi-asserted-by":"crossref","first-page":"765624","DOI":"10.1155\/2011\/765624","article-title":"The roles of interleukin-6\u00a0in the pathogenesis of rheumatoid arthritis","volume":"2011","author":"Hashizume","year":"2011","journal-title":"Arthritis"},{"key":"10.1016\/j.annder.2012.11.006_bib0095","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0030-4220(94)90087-6","article-title":"Serum cytokines, interleukin-2\u00a0receptor, and soluble intercellular adhesion molecule-1\u00a0in oral disorders","volume":"78","author":"Yamamoto","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.annder.2012.11.006_bib0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/sj.gene.6363882","article-title":"IL-1B and IL-6\u00a0gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS)","volume":"3","author":"Bazrafshani","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.annder.2012.11.006_bib0105","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.3899\/jrheum.110170","article-title":"Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?","volume":"38","author":"Wendling","year":"2011","journal-title":"J Rheumatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963812013233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963812013233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:59:56Z","timestamp":1758970796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963812013233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0151963812013233"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2012.11.006","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ulc\u00e9rations buccales aphto\u00efdes persistantes associ\u00e9es au tocilizumab\u00a0: deux cas","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2012.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}